Are There Any Approved Nanoparticle-Based Therapies?
Yes, several nanoparticle-based therapies have received regulatory approval. For example, *Doxil* is a liposomal formulation of doxorubicin approved for the treatment of ovarian cancer and multiple myeloma. Another example is *Abraxane*, a nanoparticle albumin-bound (nab) formulation of paclitaxel, approved for the treatment of breast cancer, lung cancer, and pancreatic cancer.
